FINANCING RECEIVABLES

6 Months Ended

Jun. 30, 2025

Current financing receivables and non-current financing receivables are recognized within All other current assets and All other non-current assets, respectively, in the Condensed Consolidated Statements of Financial Position.



	As of
	June 30, 2025		December 31, 2024
Loans receivable, at amortized cost	$	23	$	23
Investment in finance leases, net of deferred income	79		69
Allowance for credit losses	(2)		(2)
Current financing receivables – net	$	100	$	90

Loans receivable, at amortized cost	$	39	$	35
Investment in finance leases, net of deferred income	156		152
Allowance for credit losses	(4)		(4)
Non-current financing receivables – net	$	190	$	183

As of June 30, 2025, 2%, 2%, and 2% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of December 31, 2024, 4%, 4%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.

GE HealthCare Technologies Inc. 10-Q